Athanasios Ploumakis
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
-
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Mitochondrial Function and Pathology
Papers in
-
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 2
- CRISPR and Genetic Engineering 1
-
- Cancer Genomics and Diagnostics 1
- Co-authors
- Mathew L. Coleman (2 shared papers)Thomas Carell (1 shared paper)Bart Ghesquière (1 shared paper)Hui Zhao (1 shared paper)Anna Kuchnio (1 shared paper)Luc Schoonjans (1 shared paper)Peter Carmeliet (1 shared paper)Frédéric Amant (1 shared paper)
- Journals
- Molecular Cell (1 paper)Molecular Neurodegeneration (1 paper)Nature Immunology (1 paper)BMC Medical Genomics (1 paper)Nature (1 paper)
- Partner nations
- United StatesUnited KingdomNorway
In The Last Decade
Athanasios Ploumakis
4 papers receiving 559 citations
Athanasios Ploumakis's Hit Papers
Peers
Comparison fields: 5 of 68
- Cancer Research 223
- Molecular Biology 382
- Immunology 54
- Oncology 60
- Pulmonary and Respiratory Medicine 50
Countries citing papers authored by Athanasios Ploumakis
This map shows the geographic impact of Athanasios Ploumakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athanasios Ploumakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athanasios Ploumakis more than expected).
Fields of papers citing papers by Athanasios Ploumakis
This network shows the impact of papers produced by Athanasios Ploumakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athanasios Ploumakis. The network helps show where Athanasios Ploumakis may publish in the future.
Co-authors
The 25 scholars most cited alongside Athanasios Ploumakis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tumour hypoxia causes DNA hypermethylation by reducing TET activity Hit paper breakdown → | 2016 | 478 |
| 2 | 2015 | 60 | |
| 3 | 2024 | 26 | |
| 4 | 2019 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 |
About Athanasios Ploumakis
Athanasios Ploumakis is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Virology and Oncology, having authored 6 papers that have together received 565 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (2 papers), Cancer Genomics and Diagnostics (1 paper), HIV Research and Treatment (1 paper), Multiple Sclerosis Research Studies (1 paper), Immunotherapy and Immune Responses (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Cancer Research (223 citations), Molecular Biology (382 citations), Immunology (54 citations), Oncology (60 citations) and Pulmonary and Respiratory Medicine (50 citations). Athanasios Ploumakis has collaborated with scholars based in United States, United Kingdom and Norway. Frequent co-authors include Mathew L. Coleman, Thomas Carell, Bart Ghesquière, Hui Zhao, Anna Kuchnio, Luc Schoonjans, Peter Carmeliet, Frédéric Amant, Massimiliano Mazzone and Diether Lambrechts. Their work appears in journals such as Molecular Cell, Molecular Neurodegeneration, Nature Immunology, BMC Medical Genomics and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.